The S&P 500 (SP500) 2025 year-end price target has been raised to 5,600, reflecting 20x price-over-earnings, by Jefferies.

As the controversy over the safety of Sarepta Therapeutics’ gene therapies comes to a head, the biotech is standing firm ...

The US-based company's latest funding round has been led by private equity giant L Catterton - which itself is backed by ...

Bandhan Bank shares declined 2.36 per cent on Monday, closing at Rs 182.61, after the bank reported a 65 per cent drop in net ...

Reliance Jio's Q1 highlights include robust subscriber additions, strong performance in broadband services, and a sizable 5G ...

Defence Spending 🛡️ Right now, more than 30,000 military personnel from 19 countries are taking part in Exercise Talisman ...

Maureen Lipman reaches a significant milestone next year, but the Coronation Street star has no plans to call it a day even ...